How Blood Factors in Type 2 Diabetes May Accelerate Breast Cancer Progression
Research reveals how blood particles altered by type 2 diabetes can weaken immune responses within breast tumors, potentially increasing cancer aggression and spread. This discovery offers new insights into treating diabetic cancer patients more effectively.
Recent research from Boston University School of Medicine has uncovered a significant link between type 2 diabetes and increased breast cancer severity. The study reveals that specific particles in the blood, called exosomes, which are altered in individuals with diabetes, play a crucial role in modifying immune responses within tumors. These exosomes can reprogram immune cells, weakening their ability to combat cancer and thereby promoting tumor growth and spread.
This groundbreaking work is the first to establish a direct connection between diabetic exosomes and suppressed immune activity in human breast tumors. Using patient-derived organoids—3D tumor models containing the patient's original immune cells—researchers observed how blood exosomes from diabetic individuals influence tumor behavior. The organoids were treated with exosomes from both diabetic and non-diabetic blood samples, and single-cell RNA sequencing revealed that diabetic exosomes diminish immune cell effectiveness within the tumor microenvironment.
Dr. Gerald Denis, the lead researcher, emphasized that this discovery provides a potential explanation for why women with type 2 diabetes often experience poorer outcomes in breast cancer treatment. It also sheds light on why immunotherapies may be less effective in these patients. By understanding how diabetes impacts tumor immunity, clinicians can move toward developing more personalized and effective treatments for millions affected by both conditions.
Given that over 120 million Americans are prediabetic or diabetic, this research addresses a major public health concern. It highlights the importance of considering metabolic health in cancer management and suggests new avenues for improving treatment efficacy in diabetic cancer patients.
This study was published in Communications Biology and is available for further reference at source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Vaginal Speculum Design Aims to Reduce Fear and Discomfort During Gynecological Exams
A team of researchers has redesigned the traditional vaginal speculum to make gynecological exams more comfortable, less intimidating, and less painful, potentially improving women's healthcare experiences.
Endocrine Society Releases New Guidelines Advocating for Broader Screening of Primary Aldosteronism in Hypertension Patients
The Endocrine Society recommends broader screening for primary aldosteronism in hypertension patients to improve diagnosis and reduce cardiovascular risk. Learn about the updated guidelines and their significance.
Emerging Off-Label Use of Leucovorin Shows Promise in Helping Children with Autism Speak
Emerging research suggests that the off-label use of leucovorin, a low-cost drug, may significantly improve speech in children with autism, highlighting the need for further studies and FDA approval.
Innovative Stem Cell Transplant Eliminates Toxic Prep in Genetic Disease Treatment
Stanford Medicine researchers developed a safe and effective antibody-based method to perform stem cell transplants for genetic blood disorders without toxic chemotherapy or radiation, significantly improving patient outcomes.